Ascendis Pharma ADR
(ASND)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -478,572 | -244,178 | -153,645 | -140,041 | -75,808 |
| Depreciation Amortization | 10,793 | 7,492 | 1,039 | 830 | 749 |
| Accounts receivable | -2,280 | -2,102 | 215 | 112 | 860 |
| Accounts payable and accrued liabilities | 9,006 | 8,434 | 9,757 | 12,156 | 5,213 |
| Other Working Capital | -1,101 | 4,558 | 2,015 | 5,674 | 4,501 |
| Other Operating Activity | 151,966 | 28,748 | -23,307 | 13,778 | -2,109 |
| Operating Cash Flow | $-310,189 | $-197,048 | $-163,925 | $-107,490 | $-66,594 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 300,483 | N/A | N/A | N/A | N/A |
| PPE Investments | -18,846 | -5,778 | -3,127 | -1,064 | -744 |
| Purchase Of Investment | -614,274 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-332,637 | $-5,778 | $-3,127 | $-1,064 | $-744 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 729,698 | 592,852 | 255,551 | 150,453 | 139,394 |
| Other Financing Activity | -41,291 | -40,028 | -15,492 | -9,481 | -9,411 |
| Financing Cash Flow | $688,407 | $552,824 | $240,058 | $140,972 | $129,983 |
| Exchange Rate Effect | -61,104 | 8,676 | 24,440 | -15,439 | 4,503 |
| Beginning Cash Position | 683,217 | 311,205 | 230,710 | 203,826 | 132,404 |
| End Cash Position | 667,694 | 669,879 | 328,155 | 220,805 | 199,552 |
| Net Cash Flow | $-15,523 | $358,673 | $97,446 | $16,979 | $67,149 |
| Free Cash Flow | |||||
| Operating Cash Flow | -310,189 | -197,048 | -163,925 | -107,490 | -66,594 |
| Capital Expenditure | -24,619 | -5,778 | -3,127 | -1,064 | -744 |
| Free Cash Flow | -334,808 | -202,826 | -167,053 | -108,554 | -67,338 |